Influence of Lean Body Weight on Anticancer Drug Clearance

被引:17
作者
Mathijssen, R. H. J. [1 ]
Sparreboom, A. [1 ,2 ]
机构
[1] Dr Daniel Den Hoed Canc Ctr, Erasmus MC, Dept Med Oncol, NL-3008 AE Rotterdam, Netherlands
[2] St Jude Childrens Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA
关键词
OBESITY; SIZE;
D O I
10.1038/sj.clpt.6100511
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:23 / 24
页数:2
相关论文
共 6 条
[1]   Mechanism-based concepts of size and maturity in pharmacokinetics [J].
Anderson, B. J. ;
Holford, N. H. G. .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2008, 48 :303-332
[2]   Dosing in obesity: A simple solution to a big problem [J].
Han, P. Y. ;
Duffull, S. B. ;
Kirkpatrick, C. M. J. ;
Green, B. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 82 (05) :505-508
[3]   CYP3A phenotyping approach to predict systemic exposure to EGFR tyrosine kinase inhibitors [J].
Li, Jing ;
Karlsson, Mats O. ;
Brahmer, Julie ;
Spitz, Avery ;
Zhao, Ming ;
Hidalgo, Manuel ;
Baker, Sharyn D. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (23) :1714-1723
[4]   Flat-fixed dosing versus body surface area-based dosing of anticancer drugs in adults: Does it make a difference? [J].
Mathijssen, Ron H. J. ;
De Jong, Floris A. ;
Loos, Walter J. ;
van der Bol, Jessica M. ;
Verweij, Jaap ;
Sparreboom, Alex .
ONCOLOGIST, 2007, 12 (08) :913-923
[5]   Relationship between toxicity and obesity in women receiving adjuvant chemotherapy for breast cancer: Results from cancer and leukemia group B study 8541 [J].
Rosner, GL ;
Hargis, JB ;
Hollis, DR ;
Budman, DR ;
Weiss, RB ;
Henderson, IC ;
Schilsky, RL .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (11) :3000-3008
[6]   Evaluation of alternate size descriptors for dose calculation of anticancer drugs in the obese [J].
Sparreboom, Alex ;
Wolff, Antonio C. ;
Mathijssen, Ron H. J. ;
Chatelut, Etienne ;
Rowinsky, Eric K. ;
Verweij, Jaap ;
Baker, Sharyn D. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (30) :4707-4713